LEON NANODRUGS
leon nanodrugs a specialised product development company dedicated to developing a pipeline of enhanced versions of existing drug products, and providing services to enable pre-clinical and clinical stage formulations for their clients NCEs or branded established drugs. leon-nanodrugs offers access to the next generation of nano-formulated drugs with meaningful differentiation and added patient benefits. They specialize in improving the bioavailability of poorly water soluble drugs by using leon’s proprietary MJR® Technology platform to create either polymeric or crystalline nanoparticles.
LEON NANODRUGS
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2011-01-01
Address:
München, Bayern, Germany
Country:
Germany
Website Url:
http://www.leon-nanodrugs.com
Total Employee:
11+
Status:
Active
Contact:
+4989414248890
Email Addresses:
[email protected]
Total Funding:
20.51 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon WordPress Domain Not Resolving Sitelinks Search Box Euro Organization Schema Yoast WordPress SEO Plugin
Similar Organizations
Blade Therapeutics
Blade Therapeutics is a discovery stage drug development company.
Calimmune
Calimmune is a clinical-stage gene therapy company.
Current Employees Featured
Founder
Investors List
CD-Venture
CD-Venture investment in Series B - leon nanodrugs
LOF Leon Partnership
LOF Leon Partnership investment in Series B - leon nanodrugs
TVM Capital Life Science
TVM Capital Life Science investment in Series B - leon nanodrugs
BayBG Venture Capital
BayBG Venture Capital investment in Series B - leon nanodrugs
Albany Private Equity Holding
Albany Private Equity Holding investment in Series B - leon nanodrugs
Evotec
Evotec investment in Series B - leon nanodrugs
Eckenstein-Geigy-Stiftung
Eckenstein-Geigy-Stiftung investment in Series B - leon nanodrugs
LifeCare Partners
LifeCare Partners investment in Series A - leon nanodrugs
TVM Capital Life Science
TVM Capital Life Science investment in Series A - leon nanodrugs
Signet Healthcare Partners
Signet Healthcare Partners investment in Series A - leon nanodrugs
Newest Events participated
Participated in 7th American Drug Delivery and Formulation Summit 2017
on 2017-08-28 as sponsor
Official Site Inspections
http://www.leon-nanodrugs.com
- Host name: 185.175.196.89
- IP address: 185.175.196.89
- Location: Netherlands
- Latitude: 52.3824
- Longitude: 4.8995
- Timezone: Europe/Amsterdam
More informations about "leon nanodrugs"
leon nanodrugs - Crunchbase Company Profile
Leon-nanodrugs is a nanotechnology-based drug development company. leon …See details»
leon nanodrugs Company Profile - Office Locations, Competitors …
Leon nanodrugs has 5 employees across 2 locations and $28.68 m in total funding,. See insights on leon nanodrugs including office locations, competitors, revenue, financials, executives, …See details»
Leon Nanodrugs - PitchBook
Leon Nanodrugs General Information Description. Developer of drugs through …See details»
About LEON - leon-nanodrugs GmbH - Innovations- und …
Leon-nanodrugs GmbH. About LEON. leon-nanodrugs GmbH (“LEON”) is a pharmatech company specializing in the development and marketing of its innovative technology for the …See details»
leon-nanodrugs - ONdrugDelivery
Leon-nanodrugs delivers novel, validated and optimised pharmaceutical nanotechnology solutions that create value for clients and provide better …See details»
leon nanodrugs - Org Chart, Teams, Culture & Jobs - The Org
View leon nanodrugs' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
leon-nanodrugs GmbH - Company Profile and News
Leon-Nanodrugs GmbH operates as a pharmaceutical company. The Company develops a pipeline of enhanced versions of existing drug products, as well as provides services to enable …See details»
leon-nanodrugs secures funds in a series D financing …
MUNICH, Aug. 06, 2024 (GLOBE NEWSWIRE) -- leon-nanodrugs GmbH (LEON), a pharmatech company specializing in the development of …See details»
About us - Leon Nanodrugs
LEON and Evotec’s strategic partnership will maximise the effectiveness of clinical and commercial nano-medicine development. Eckenstein-Geigy …See details»
leon nanodrugs - Funding, Financials, Valuation & Investors
Their latest funding was raised on Aug 6, 2024 from a Series D round. leon nanodrugs is funded by 12 investors. Signet Healthcare Partners and Albany Capital are the most recent investors. …See details»
leon-nanodrugs (leon-nanodrugs GmbH) - Startbase
Nachrichten über leon-nanodrugs Umfassende Startup-Listen: Startups aus München Startups aus Bayern Startups aus Deutschland. Die neusten Erwähnungen von leon-nanodrugs in …See details»
Leon-nanodrugs GmbH | Leon-nanodrugs Appoints Dr. Wolfgang …
6 hours ago Munich-based leon-nanodrugs GmbH announces the appointment of Dr. Wolfgang Hofmann as its new Chief Executive Officer. This strategic move comes as the company …See details»
LEON successfully completes development of its innovative
Jan 3, 2023 leon-nanodrugs’ (“LEON”) aim is to create a new norm for the production of nanoparticle-based therapeutics by establishing their technology for seamless scale-up and …See details»
Our Services - Leon Nanodrugs
Leon-nanodrugs GmbH Am Klopferspitz 19, D-82152 Planegg Germany. Phone ...See details»
leon-nanodrugs appoints Dr. Wolfgang Hofmann as Chief …
6 hours ago leon-nanodrugs appoints Dr. Wolfgang Hofmann as Chief Executive Officer as company’s products approach market. Munich, Planegg (Germany), June 4, 2025 – leon …See details»
2025 - About us - Leon Nanodrugs
She began her career at Krka, where she gained hands-on experience in development and manufacturing. Since joining LEON, Maja has contributed across multiple functions, initially …See details»
News & Events - Leon Nanodrugs
Mar 25, 2025 CONTACT. leon-nanodrugs GmbH Am Klopferspitz 19, D-82152 Planegg. Phone +49(0)89 41 42 48 89-0 Fax +49(0)89 41 42 48 89-88 Follow usSee details»
LEON completes development of its innovative reactor - Leon …
Jan 3, 2023 About LEON. leon-nanodrugs GmbH is a Munich-based pharmatech company specializing in the development of devices for the encapsulation of genetic material and other …See details»
EQS-News: leon-nanodrugs ernennt Dr. Wolfgang Hofmann zum …
6 hours ago EQS-News: leon-nanodrugs GmbH / Schlagwort(e): Personalie leon-nanodrugs ernennt Dr. Wolfgang Hofmann zum Chief Executive Officer und bereitet den Markteintritt vor …See details»
The Mikal Bridges reason Stephen A. Smith called out Knicks GM …
Albeit, Bridges had a decent regular season in his debut year with the Knicks. The 28-year-old forward ended the 2024-15 campaign averaging 17.6 points, 3.2 rebounds, and 3.7 assists per …See details»